
    
      A Single-centre, Open-label, PET imaging and Pharmacokinetic Study of IV Administered
      [11C]osimertinib in EGFRm Non-small cell lung cancer patients with brain metastases. The
      study will consist of 2 phases, an imaging phase and a continuous access phase.
    
  